A Study of Efficacy and Tolerability of Rosehip Extract (Gopo) vs. Ibuprofen (a nsaid) in Treatment of Osteoarthritis in Weight Bearing Joints
Introduction: Osteoarthritis is the most common form of arthritis. Osteoarthritis is a joint failure, which occurs due to pathological change in all structure joint. Aim: The aim of the study was to compare the efficacy and tolerability of Rosehip Extract and ibuprofen along with individual effect of both drugs. Materials and Methods: This was an open, randomized, prospective study to compare ROSE HIP Extract and IBUPROFEN for treatment of Osteoarthritis in 100 patients. In this study two comparative groups (50 each) were taken. First group was prescribed 400 mg TDS Ibuprofen and the other group was given Rose hip extract in the form of 275 mg capsule BD. The pain assessment was done through Womac scale and visual analogue scale. The data was collected for efficacy and tolerability for both drugs at 14 days and 3 months. Result: In ibuprofen group, the mean score of pain intensity on womac scale on visit 1 was 39.2 ± 9.58 which was decreased to 11.62 ± 4.97 in the last visit. On VAS scale on visit 1 was 7.26 ± 1.426 and was decreased to 3.36 ± 1.467 at visit 3. In rosehip group. The mean score of pain intensity on WOMAC scale on visit 1 was 38.44 ± 8.45, 30.88 ± 8.068 which was decreased to 26.68 ± 8.474. The mean score of pain intensity at on VAS scale on visit 1 was 7.02 ± 1.06, 5.84 ± 1 and was decreased to 4.6 ± 1.16 at the end of study. Conclusion: Ibuprofen is a better choice than rosehip because it had shown better improvement. Both rosehip and ibuprofen were well tolerated.
How to Cite
Lal, H., Singh, H., Sandhu, K. S., & Sehgal, V. K. (2019). A Study of Efficacy and Tolerability of Rosehip Extract (Gopo) vs. Ibuprofen (a nsaid) in Treatment of Osteoarthritis in Weight Bearing Joints. International Journal of Medical and Dental Sciences, 1754–1758. https://doi.org/10.18311/ijmds/2019/23417
- Walker BR, Colledge NR, Ralston S, Penmann ID. Editors Davidson’s principles and practice of medicine 22nd ed. Edinburgh: Churchill Livingstone/Elsevier; 2014.
- Pal CP, Singh P, Chaturvedi S, Pruthi KK, Vij A. Epidemiology of knee osteoarthritis in India and related factors. Indian J Orthop. 2016; 50(5):518–22. https://doi.org/10.4103/00195413.189608 PMid:27746495 PMCid:PMC5017174
- Maskowitz RW. Osteoarthritis: Epidemiology, clinical aspect and general management. AMJ Med. 1987; 5 (5):83. https://doi.org/10.1016/0002-9343(87)90844-8
- Hart DJ, Doyle DV, Spector TD. Incidence and risk factors for radiographic knee osteoarthritis in middle-aged women: The Chingford Study. Arthritis Rheum 1999 Jan; 42(1):17e24.
- Felson DT, Anderson J, Naimark A. Obesity and Knee osteoarthritis: the Framingham study. Ann International Medicine. 1991; 18:109.
- Silverwood V, Bucknall MB, Jinks C, Jordan JL, Protheroe J, Jordan KP. Current evidence on risk factors for knee osteoarthritis in older adults: a systematic review and meta-analysis. Osteoarthr Cartil. 2015; 23: 507-515. https://doi.org/10.1016/j.joca.2014.11.019 PMid:25447976
- Katzung BG, Trevor AJ. Editors. Basic and clinical pharmacology. 14th ed. New Delhi: Mcgraw Hill; 2018.
- Winther K, Vinther AS, Hansen, Tofte JC. Bioactive ingredients of rose hips (Rosa caninaL) with special reference to ant oxidative and anti-inflammatory properties: in vitro studies. Botanics: Targets and Therapy. 2016; 6:11– 23. https://doi.org/10.2147/BTAT.S91385
- Kharazami A, Winther K. Rosehip inhibits chemotaxis and chemiluminescence of human peripheral blood neutrophils in vitro and reduces certain inflammatory parameters in vivo. Inflammopharmacology. 1999; 7(4):371–86.
- Cohen M. Rosehip an evidence based herbal medicine for inflammation and arthritis. Aust Fam Physician. 2012 Jul; 41(7): 495-98. PMid:22762068
- Srikanth VK, Fryer JL, Zhai G, Winzenberg TM, Hosmer D, et al. A meta-analysis of sex differences prevalence, incidence and severity of osteoarthritis. Osteoarthr Cartil. 2005; 13(9):769–81. https://doi.org/10.1016/j.joca.2005.04.014 PMid:15978850
- Baumgartner H, Schwarz HA, Blum W, Bruhin A, Gallachi G, Goldinger G et al. Ibuprofen and diclofenac sodium in the treatment of osteoarthritis: a comparative trail of two once daily sustained release NSAID formulations. Cur Med Res Opin. 1996; 13(8):435–44. https://doi.org/10.1185/03007999609115224 PMid:9010610
- Earl ET, Jenkins R, Munro AJ. Double-masked comparison of the efficacy of once-daily sustained-release ibuprofen and once-daily piroxicam for 24-hour control of arthralgia due to osteoarthritis in the elderly. Cur Ther Res. 1996; 50(10):81121. https://doi.org/10.1016/S0011-393X(96)80087-7
- Salaffi F, Leardini G, Canesi B., Mannoni A, Fioravanti A, CaporaliR, et al. Reliability and validity of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index in Italian patients with osteoarthritis of the knee. Osteoarthr Cartil. 2003; 11(8):551–60. https://doi.org/10.1016/S1063-4584(03)00089-X
- Warlhom O, Skaar S, Hedman E, Molem HM, Eik L. The effects of a standardized herbal remedy made from a subspecies of Rosa Canina in patients with osteoarthritis: A double blind, randomized, placebo controlled clinical trial. Curr Ther Res Clin Exp. 2003; 64(1):21–31. https://doi.org/10.1016/S0011-393X(03)00004-3
- Christensen R, Bartels EM, Bliddal H. Efficacy of glucosamine hydrochloride or specialised Rosehip powder in osteoarthritis patients: an indirect comparison metaanalysis. Osteoarthr Cartil. 2009; 17(1):S279.
- Winther K, Apel K, Thamsborg G. A powder from seeds and shells of Rosehip subspecies (Rosa Canina) reduces symptoms of knee and hip osteoarthritis: a randomized, double-blind, placebo controlled clinical trial. Scand J Rheumatol. 2005; 34:302-08. https://doi.org/10.1080/03009740510018624 PMid:16195164